Ligand validation:6GM9

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 6GM9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GM9_BGC_A_303	95%	90%	0.077	0.981	0.21	0.39	-	-	0	0	100%	0.68
6GM9_BGC_A_304	29%	91%	0.144	0.799	0.22	0.36	-	-	0	0	100%	0.66
6I0W_BGC_A_305	92%	88%	0.078	0.969	0.2	0.46	-	-	0	0	100%	0.68
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	0.9167
4IIG_BGC_B_950	100%	50%	0.035	0.987	0.78	1.13	-	2	1	0	100%	1
2V3G_BGC_A_1281	100%	68%	0.051	0.994	0.52	0.69	-	-	0	0	100%	1
5DNF_BGC_A_102	100%	26%	0.047	0.988	2.1	0.95	3	1	0	0	100%	1
3ACT_BGC_B_3901	99%	47%	0.05	0.988	0.92	1.12	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.